Cite
MLA Citation
G. Francolini et al.. “PD-0849 Concomitant Nivolumab and RT in metastatic kidney cancer. Benefit of ablative vs palliative approach.” Radiotherapy and oncology, vol. 161, n.d., pp. S683–. http://access.bl.uk/ark:/81055/vdc_100144486235.0x00005b